Without an H1N1 pandemic this year, cough-cold medicines will be challenged by high sales hurdles over the first half of the season, and relatively weak comparable cough-cold sales over the second half.
Without an H1N1 pandemic this year, cough-cold medicines will be challenged by high sales hurdles over the first half of the season, and relatively weak comparable cough-cold sales over the second half.
Credit: 
3209DSN_OverTheCounter1-fig2.jpg
© 2014 Drug Store News. All Rights Reserved.